Canagliflozin hemihydrate

Canagliflozin hemihydrate

Canagliflozin hemihydrate (trade name Invokana, Sulisent, Prominad is a highly potent and selective SGLT2 inhibitor to treat type 2 diabetes. Canagliflozin has been approved by US FDA on March 29, 2013.

Specifications

Product Name:                  Canagliflozin hemihydrate

Synonyms:                         JNJ 28431754; TA 7284; (1S)-1,5-anhydro-1-C-(3-{[5-(4-fluorophenyl)thiophen-2-yl]methyl]}-4-methylphenyl)-D-glucitol

CAS Number:                     928672-86-0

Molecular Weight:            444.5169

Molecular Formula:          C24H25FO5S

Purity (HPLC):                     ≥99%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               OCC1OC(c2ccc(c(c2)Cc2ccc(s2)c2ccc(cc2)F)C)C(C(C1O)O)O.OCC1OC(c2ccc(c(c2)Cc2ccc(s2)c2ccc(cc2)F)C)C(C(C

  • $138.00
  • Ex Tax: $138.00

Available Options